RxDoctor Payments Data

John Ryzenman, MD

Otology & Neurotology · Gahanna, OHNPI 1871501437

Payments from drug & device makers

What this record shows

5 manufacturers reported payments, led by Med-el Corporation at 45.7% of the total. Reporting peaked in 2019 at $1,342 and has fallen 85.2% since, to $199 in 2025.

$3,724in general payments, 2019–2025

Across 33 payments — averaging $112.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Med-el Corporation$2K
  • Medtronic$966
  • Stryker$550
  • Cochlear Americas$483
  • Alk-abello, Inc$24
$6,757in research payments, 2019–2025

Across 12 payments — averaging $563.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Cochlear Americas$7K

What the payments were for

  • Travel & lodging$1,90051%
  • Food & beverage$1,82349%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Med-el Corporation12$1,701
Medtronic7$966
Stryker6$550
Cochlear Americas6$483
Alk-abello, Inc2$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few otology & neurotology providers in Ohioto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$68,909
Medicare patients
140
Services billed
390

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin75$3,278
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth20$2,093
Tobramycin-DexamethasoneTobramycin/Dexamethasone21$1,140
ValacyclovirValacyclovir Hcl12$429
Doxycycline Hyclate21$194
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen37$182
Cephalexin31$178
Methylprednisolone30$134
Prednisone20$49
Promethazine Hcl20$28

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in Gahanna

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →